Literature DB >> 18078359

Narcolepsy and excessive daytime sleepiness: diagnostic considerations, epidemiology, and comorbidities.

Ruth M Benca1.   

Abstract

Narcolepsy is a chronic, neurologic disorder that has severe disabling effects on affected patients. It usually becomes manifest between the ages of 10 and 25 years and is recognized by a tetrad of symptoms that includes excessive daytime sleepiness, cataplexy, sleep paralysis, and hypnagogic hallucinations. Excessive daytime sleepiness is common and associated with a broad range of medical, sleep, and psychiatric disorders; therefore, accurate diagnosis of narcolepsy and comorbid disorders is important for optimal treatment response.

Entities:  

Mesh:

Year:  2007        PMID: 18078359

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  8 in total

1.  Narcolepsy presenting as schizophrenia: a literature review and two case reports.

Authors:  Farid Ramzi Talih
Journal:  Innov Clin Neurosci       Date:  2011-04

2.  The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness.

Authors:  Christopher Drake; Timothy Roehrs; Naomi Breslau; Eric Johnson; Catherine Jefferson; Holly Scofield; Thomas Roth
Journal:  Sleep       Date:  2010-06       Impact factor: 5.849

Review 3.  Disrupted nighttime sleep in narcolepsy.

Authors:  Thomas Roth; Yves Dauvilliers; Emmanuel Mignot; Jacques Montplaisir; Josh Paul; Todd Swick; Phyllis Zee
Journal:  J Clin Sleep Med       Date:  2013-09-15       Impact factor: 4.062

4.  The nightmares of Puerto Ricans: an embodied 'altered states of consciousness' perspective.

Authors:  C Jeffrey Jacobson
Journal:  Cult Med Psychiatry       Date:  2009-06

5.  Hypocretin Mediates Sleep and Wake Disturbances in a Mouse Model of Traumatic Brain Injury.

Authors:  Hannah E Thomasy; Mark R Opp
Journal:  J Neurotrauma       Date:  2018-10-03       Impact factor: 5.269

6.  Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders.

Authors:  Francesca Canellas; Ling Lin; Maria Rosa Julià; Antonio Clemente; Cristofol Vives-Bauza; Hanna M Ollila; Seung Chul Hong; Susana M Arboleya; Mali A Einen; Juliette Faraco; Marcelo Fernandez-Vina; Emmanuel Mignot
Journal:  J Clin Sleep Med       Date:  2014-09-15       Impact factor: 4.062

Review 7.  pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy.

Authors:  Noeen Sarfraz; David Okuampa; Hannah Hansen; Mark Alvarez; Elyse M Cornett; Juyeon Kakazu; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-05-30

8.  Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.

Authors:  Thomas C Thannickal; Robert Nienhuis; Jerome M Siegel
Journal:  Sleep       Date:  2009-08       Impact factor: 5.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.